论文信息 - Biomarker Associations With Survival for Refractory NSCLC Patients Receiving Erlotinib +/- Sunitinib in a Randomized Phase 2 Trial - 字舞流文

Biomarker Associations With Survival for Refractory NSCLC Patients Receiving Erlotinib +/- Sunitinib in a Randomized Phase 2 Trial

M. Socinski | C. Gridelli | L. Tye | R. Chao | F. Grossi | G. Blumenschein | H. Groen | F. Gao | C. Harmon | J. A. Williams